Tübingen, Germany-based SHS Capital, a firm that claims to be building European healthcare champions, announced on Wednesday that it has completed the final closing of its sixth fund generation at €270M, exceeding its original target of €200M due to high demand.
The fund, SHS VI, will focus on supporting the growth of healthcare companies in Europe.
Investors supporting the new fund
The group of investors in SHS VI includes fund of funds, insurance companies, pension funds, foundations, family offices, banks, healthcare corporates, church investors, and entrepreneurs.
The SHS investment team has also made significant personal investments in the fund, highlighting their strong commitment in the firm’s investment strategies and the potential for success in the European healthcare sector.
Sascha Alilovic, SHS Managing Partner, says, “The volume of the new fund has significantly exceeded our expectations and confirmed our positioning as the leading private equity healthcare specialist in Germany, and thus the largest European healthcare market.”
“We are very pleased that many of SHS’s investors in previous funds have also invested in our new fund, in some cases with significantly increased subscriptions.”
“In addition, we were able to further internationalise our pool of investors and expand it with renowned addresses. We would like to thank our investors for their trust,” adds Alilovic.
SHS VI to back 15 companies
SHS VI aims to make 10 to 15 investments, ranging from €10M to €40M each, with the potential to reach transaction values of up to €150M in collaboration with LPs and other investors.
The fund exclusively targets companies that already have substantial revenues, are on a growth trajectory, and aspire to become leaders in the European healthcare sector.
SHS Capital leverages its healthcare industry network, deep experience, and market knowledge to support these companies in achieving their goals, emphasising its commitment to fostering European healthcare champions.
Since the first closing of SHS Capital’s new fund in the previous summer, the firm has already made four investments from it, adding to a total of 13 investments and 13 exits since 2020.
Manfred Ulmer-Weber, Managing Partner at SHS, says, “The healthcare sector is an indispensable sector and therefore offers numerous exciting opportunities for investments. With us, investors have the chance to participate in the development of this growth market.”
“Our track record shows attractive returns for our investors and at the same time contribute to improving the healthcare system through innovations and optimising patient care,” adds Ulmer-Weber.
Brief about SHS Gesellschaft für Beteiligungsmanagement mbH
Founded in 1993 SHS Capital specialises in investing in healthcare companies across Europe. Its investments are primarily directed towards expansion financing, shareholder changes, and succession situations.
The firm follows an investment philosophy called “Building European Healthcare Champions”, which involves providing financial support and developmental guidance to portfolio companies.
SHS Capital is flexible in its investment approach, taking both minority and majority stakes in companies. Typically, the firm investments range up to €40M in equity or equity-like financing, but they can leverage co-investor networks for larger investments.
SHS Capital also places a strong emphasis on considering environmental, social, and governance (ESG) factors in its investment decisions, adhering to the principles outlined by the United Nations Principles for Responsible Investment (UN PRI).
01
Job board for modern workforce: How Remote Talent helps jobseekers find truly remote, distributed work